This is not the most recent version of the article. View current version (11 MAR 2016)

Intervention Protocol

You have free access to this content

Pharmacological treatment for Buerger's disease

  1. Daniel G Cacione1,*,
  2. Jose CC Baptista-Silva2

Editorial Group: Cochrane Vascular Group

Published Online: 22 MAR 2014

DOI: 10.1002/14651858.CD011033

How to Cite

Cacione DG, Baptista-Silva JCC. Pharmacological treatment for Buerger's disease (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD011033. DOI: 10.1002/14651858.CD011033.

Author Information

  1. 1

    UNIFESP/EPM, Surgery, Sao Paulo, Brazil

  2. 2

    Universidade Federal de São Paulo, Surgery and Evidence Based Medicine, Brazilian Cochrane Centre, São Paulo, São Paulo, Brazil

*Daniel G Cacione, Surgery, UNIFESP/EPM, Rua Borges Lagoa, 564 cj 124, Vila Clementino, Sao Paulo, 04038000, Brazil.

Publication History

  1. Publication Status: New
  2. Published Online: 22 MAR 2014


This is not the most recent version of the article. View current version (11 MAR 2016)


Additional references

Brunton 2011
  • Brunton LL, Chabner BA, Knollmann BC (editors). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th Edition. New York: McGraw-Hill Companies, 2011.
Buerger 1908
  • Buerger L. Thrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. American Journal of Medicine 1908;136:567-80.
Cachovan 1988
  • Cachovan M. Epidemiology and geographic distribution of the thromboangiitis obliterans [Epidemiologic und geographisches Verteilungsmuster der thromboangiitis obliterans]. Thromboangiitis obliterans Morbus Winiwarter-Buerger. Heidrich H. Stuttgart, 1988:31-6.
Chapman 2003
  • Chapman TM, Goa KL. Cilostazol: a review of its use in intermittent claudication. American Journal of Cardiovascular Drugs 2003;3(2):117-38.
Cooper 2004
  • Cooper LT, Tse TS, Mikhail MA, McBane RD, Stanson AW, Ballman KV. Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease). Journal of the American College of Cardiology 2004;44(12):2410-1.
De Haro 2009
  • De Haro J, Florez A, Fernadez JL, Acin F. Treatment of Buerger disease (thromboangiitis obliterans) with bosentan: a case report. BMJ Case Reports 2009. [DOI: 10.1136/bcr.08.2008.0691]
Dindyal 2009
  • Dindyal S, Kyriakides C. A review of cilostazol, a phosphodiesterase inhibitor, and its role in preventing both coronary and peripheral arterial restenosis following endovascular therapy. Recent Patents on Cardiovascular Drug Discovery 2009;4(1):6-14.
Fontaine 1954
  • Fontaine R, Kim M, Kieny R. Surgical treatment of peripheral circulation disorders [Die chirugische Behandlung der peripheren Durchblutungsstörungen]. Helvetica Chirurgica Acta 1954;21(5/6):499-533.
Grant 1992
  • Grant SM, Goa KL. Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures. Drugs 1992;43(6):889-924.
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from
Iwai 2005
  • Iwai T, Inoue Y, Umeda M, Huang Y, Kurihara N, Koike M, et al. Oral bacteria in the occluded arteries of patients with Buerger disease. Journal of Vascular Surgery 2005;42(1):107-15.
Launay 2006
  • Launay D, Diot E, Pasquier E, Mouthon L, Boullanger N, Fain O, et al. Bosentan for treatment of active digital ulcers in patients with systemic sclerosis. La Presse Médicale 2006;35(4 Pt 1):587-92.
Li 2008
Malecki 2009
Matucci-Cerinic 2011
  • Matucci-Cerinic M, Denton CP, Furst DE, Mayes MD, Hsu VM, Carpentier P, et al. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Annals of the Rheumatic Diseases 2011;70(1):32-8.
Novo 2004
  • Novo S, Coppola G, Milio G. Critical limb ischemia: definition and natural history. Current Drug Targets 2004;4(3):219-25.
Olin 2000
Olin 2006
Robless 2008
Ruffolo 2010
Rutherford 2005
  • Rutherford RB. Vascular Surgery. 6th Edition. Vol. 1, New York: Elsevier Inc., 2005.
Safdar 2011
Shionoya 1983
von Winiwarter 1879
  • von Winiwarter F. A peculiar form of endarteritis and endophlebitis with gangrene of the foot [Ueber eine eigenthümliche Form von Endarteriitis und Endophlebitis mit Gangrän des Fusses]. Archiv für Klinische Chirurgie 1879;23:202-26.
Weber 1996
Weinberg 2012